About Matchpoint Therapeutics
Matchpoint Therapeutics discovers precision small molecule medicines that use covalency to treat immune diseases and other serious illnesses. The company uses its Advanced Covalent Exploration platform, which integrates chemoproteomics, machine learning, and covalent chemistry library evolution. Matchpoint has an emerging pipeline of novel covalent medicines.
Company Details
Corporate & Operational Profile
Web & Domain Identity
Social & Network Presence
Company Milestones & Timeline
- Capital Raise
Raised $150,000,000 · Series-B
Backed by Nextech Invest, Norwest Venture Partners
- Capital Raise
Raised $100,000,000 · Series-A
Backed by Sanofi Ventures, Access Biotechnology
- Milestone
X account created (@matchpointtx)
134 followers
- Milestone
Website domain registered
matchpointtx.com
- Milestone
Company founded
Cambridge, United States
Investors & Backers
Funding History
Round backers: Nextech Invest, Norwest Venture Partners, Access Biotechnology, Atlas Venture, BB Biotech, BOLD Longevity Growth Fund, Digitalis Ventures, Invus, Sanofi Ventures, T1D Fund
Round backers: Sanofi Ventures, Access Biotechnology, Alexandria Venture Investments, Atlas Venture, Digitalis Ventures, Vertex Ventures HC, citybiz
Founders & Leadership
Edward Chouchani
Founder
G. Andre Turenne
President and CEO
Jared Cumming
Chief Scientific Officer
Jianwei Che
Founder
Nathanael Gray
Founder
Tinghu Zhang
Founder
Press Coverage & Sources
bioworld.com/articles/734544-new-financing-at-matchpoint-therapeutics-to-advance-lead-program
news.google.com/rss/articles/CBMijwFBVV95cUxNaWdQUVU3eTEta051VVo3ZFRpQVRoWmRsQVNnb0d6TWZ6d1ROU3M1SUVTRldFR3l3aGxYem1vRGxCUjV3SkU0aGY5NU5WU1ZlcWh5UzlEZmpWbHh5T3VWZkZjQ0lQNS11OUdDVUxGdmlzd2tVaDBocWlyckxsUXFqTUotU2JkYi1tcnR3UE5TUQ
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Hexagon Bio
hexagonbio.com
RefloDx
reflodx.com
HeyVoli
heyvoli.com
CureBay
curebay.com
4Tissue
4tissue.com